National Cancer Institute et al., 2026-11-18: NCI's current testicular cancer statistics: 5-year relative survival 94.6% for 2016-2022, against 79.69% for 1975 in the page's trend table. Estimated 9,810 new cases and 630 deaths in 2026.
5-Year Relative Survival 94.6% 2016-2022
Statistics at a Glance (data field); survival trend table on the same page
National Cancer Institute et al., 2026-11-18: NCI's current testicular cancer statistics: 5-year relative survival 94.6% for 2016-2022, against 79.69% for 1975 in the page's trend table. Estimated 9,810 new cases and 630 deaths in 2026. US government work. Two counter-current details the book can use, both from the page's own Trends section: age-adjusted death rates for testicular cancer have been RISING 2.3% per year over 2015-2024, and incidence rising 0.7% per year. The 1975 figure of 79.69% already reflects the cisplatin era, so the SEER series understates the pre-1974 change (see CHD-06). Excerpt is a data field, not a sentence; the page is web-only and has no PDF edition. Study type: other.
